Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Regulators Seek Unified Approach To Remote Inspections

Executive Summary

Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.

You may also be interested in...



How The European Medicines Agency Inspected Thermo Fisher’s Florida Plant Without Leaving Europe

Contract development and manufacturing organization relied on combination of immersive mixed-reality devices to host remote inspection.

GCP Inspections 'Indispensable' During Pandemic

The European Medicines Agency says good clinical practice inspections are indispensable even in the midst of a pandemic. It has set out requirements and specificities of undertaking inspections remotely where feasible. 

Global Pharma Guidance Tracker – July 2022

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS143635

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel